logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10745481 B1

PDFFull Text
Date of Patent:
Aug. 18, 2020

Filed:

May. 04, 2016

Anti-cd166 antibodies, activatable anti-cd166 antibodies, and methods of use thereof

Applicant:

Cytomx Therapeutics, Inc., South San Francisco, CA (US);

Inventors:

James William West, Bend, OR (US);

Jason Gary Sagert, San Mateo, CA (US);

Jonathan Alexander Terrett, Cupertino, CA (US);

Annie Yang Weaver, San Mateo, CA (US);

Luc Roland Desnoyers, San Francisco, CA (US);

Shweta Singh, Fremont, CA (US);

Assignee:

CytomX Therapeutics, Inc., South San Francisco, CA (US);

Attorneys:

Cooley LLP

Ivor Elrifi

Cynthia Kozakiewicz

Primary Examiner:

Karen A Canella

Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 31/537 (2006.01); A61K 39/00 (2006.01); A61K 47/68 (2017.01);
U.S. Cl.
CPC ...
C07K 16/2803 (2013.01); A61K 31/537 (2013.01); A61K 47/6873 (2017.08); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/73 (2013.01); C07K 2317/732 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2319/50 (2013.01); C07K 2319/55 (2013.01);
Abstract

The invention relates generally to antibodies that bind CD166, activatable antibodies that specifically bind to CD166 and methods of making and using these anti-CD166 antibodies and anti-CD166 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.

Find Patent Forward Citations

West, James. (2020). Anti-cd166 antibodies, activatable anti-cd166 antibodies, and methods of use thereof (U.S. Patent No. 10745481). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10745481

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…